| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9497496bf391788d5503001d468b7f78 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
1997-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb77de47cbf7a5f323a0b3774a91adb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1bf4797a1ab01d0705192062d833b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49e2f9044c82ca97168853a9b98d452d |
| publicationDate |
2000-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20000022141-A |
| titleOfInvention |
Isolated nucleic acid molecule encoding GAGE tumor rejection antigen, tumor rejection antigen and use thereof |
| abstract |
The present invention relates to a new family of tumor rejecting antigen precursors, and nucleic acid molecules encoding them. Such tumor rejection antigen precursors are termed GAGE tumor rejection antigen precursors, and the nucleic acid molecules encoding them are termed GAGE coding molecules. Various diagnostic and therapeutic uses of coding sequences and tumor rejection antigens, and precursor molecules thereof, are described. Tumor rejection antigens are also described. |
| priorityDate |
1996-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |